What is the ROCE (Return on Capital Employed) of bioXXmed this year?
The ROCE of bioXXmed is -0.04 undefined this year.
bioXXmed ROCE 2024
bioXXmed ROCE
-0.04
Ticker
T5O.DE
ISIN
DE000A0KFRJ1
WKN
A0KFRJ
In 2024, bioXXmed's return on capital employed (ROCE) was -0.04, a -55.1% increase from the -0.09 ROCE in the previous year.
bioXXmed Aktienanalyse
What does bioXXmed do?
CytoTools AG is a German biotechnology company based in Darmstadt. It was founded in 2000 and has been listed on the Frankfurt Stock Exchange since 2006. The company focuses on the development of innovative therapies for diseases that have been difficult or impossible to treat so far. CytoTools relies on the use of active substances developed based on endogenous (body's own) molecules. A particular focus is on the research and development of active substances for the treatment of diseases based on inflammatory processes. CytoTools works closely with international research and development partners in this area. CytoTools' business model is based on the development and marketing of products based on innovative technologies and active substances. As a biotechnology company, it specializes in the development of patent-protected products and pursues a scalable business model. The company is divided into various divisions. In the "Pharmaceuticals" division, CytoTools develops innovative active substances and drugs for the treatment of diseases such as inflammatory diseases, cancer, or diabetes. An example of this is the active substance DermaPro, which can be used to treat chronic wounds. In the "Medical Devices" division, CytoTools develops medical devices for the diagnosis and therapy of diseases. An example of this is the CytoSorb system, which is used for extracorporeal blood detoxification and thus supports the treatment of severe infectious and inflammatory diseases. The third division of CytoTools is "Diagnostics". Here, the company develops innovative diagnostic tools for early detection of diseases. An example of this is the biomarker-based rapid test DermaPro Inflammation Score, which allows for a quick and reliable assessment of the inflammatory state of wounds. CytoTools has a strong network of partners and cooperation partners. The most important partners include institutions such as Kiel University, Flensburg University, or the Institute of Molecular Biotechnology in Jena. In addition, CytoTools works closely with international partners from the pharmaceutical industry. Overall, CytoTools is an innovative and rapidly growing biotechnology company specializing in the development of patent-protected products and technologies for the treatment of severe and previously incurable diseases. With its strong network of research and development partners and a wide range of products, the company is well-positioned to continue growing and develop new therapy concepts in the future. bioXXmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling bioXXmed's Return on Capital Employed (ROCE)
bioXXmed's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing bioXXmed's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
bioXXmed's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in bioXXmed’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about bioXXmed stock
How has the ROCE (Return on Capital Employed) of bioXXmed developed compared to the previous year?
The ROCE of bioXXmed has increased by -55.1% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of bioXXmed?
A high Return on Capital Employed (ROCE) indicates that bioXXmed has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of bioXXmed?
A low ROCE (Return on Capital Employed) can indicate that bioXXmed has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from bioXXmed impact the company?
An increase in the ROCE of bioXXmed can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of bioXXmed affect the company?
A decrease in ROCE of bioXXmed can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of bioXXmed?
Some factors that can affect bioXXmed's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of bioXXmed so important for investors?
The ROCE of bioXXmed is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can bioXXmed take to improve the ROCE?
To improve the ROCE, bioXXmed can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does bioXXmed pay?
Over the past 12 months, bioXXmed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, bioXXmed is expected to pay a dividend of 0 EUR.
What is the dividend yield of bioXXmed?
The current dividend yield of bioXXmed is .
When does bioXXmed pay dividends?
bioXXmed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of bioXXmed?
bioXXmed paid dividends every year for the past 0 years.
What is the dividend of bioXXmed?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is bioXXmed located?
bioXXmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von bioXXmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of bioXXmed from 12/4/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.
When did bioXXmed pay the last dividend?
The last dividend was paid out on 12/4/2024.
What was the dividend of bioXXmed in the year 2023?
In the year 2023, bioXXmed distributed 0 EUR as dividends.
In which currency does bioXXmed pay out the dividend?
The dividends of bioXXmed are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von bioXXmed
Our stock analysis for bioXXmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of bioXXmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
